Table 5.
Univariate and multivariate analyses of prognostic factors for overall survival in validation cohort II.
| Variables | Univariate | Multivariate | |||||
|---|---|---|---|---|---|---|---|
| Log-rank χ2 | P value | B | SE | HR | 95% CI | P value | |
| Age, years (> 55/≤ 55) | 0.665 | 0.415 | |||||
| Gender (male/female) | 0.525 | 0.469 | |||||
| Ascites (yes/no) | 0.026 | 0.872 | |||||
| Laboratory parameters | |||||||
| ALP, U/L (> 200/≤ 200) | 7.166 | 0.007* | 0.333 | 0.656 | 1.395 | 0.388 to 5.009 | 0.612 |
| ALB, g/L (> 36/≤ 36) | 3.871 | 0.049* | -0.455 | 0.526 | 0.634 | 0.228 to 1.767 | 0.386 |
| AFP, ng/dL (> 400/≤ 400) | 0.089 | 0.765 | |||||
| BUN, mmol/L (> 8.9/≤ 8.9) | 43.877 | <0.001* | 1.526 | 2.789 | 1.542 | 0.153 to 5.676 | 0.956 |
| T category (T1-2/T3-4) | 8.633 | 0.003* | 0.538 | 2.561 | 1.713 | 0.257 to 6.556 | 0.999 |
| N category (N0/N1) | 1.699 | 0.192 | |||||
| M category (M0/M1) | 0.483 | 0.487 | |||||
| TNM (Ⅰ-II/III-IV) | 8.578 | 0.003* | 2.248 | 2.562 | 1.467 | 0.434 to 5.235 | 0.999 |
| PVTT (yes/no) | 2.587 | 0.108 | |||||
| Child-Pugh grade (A/B) | 0.043 | 0.837 | |||||
| AAPR (> 0.439/≤ 0.439) | 17.336 | < 0.001* | -0.517 | 0.254 | 0.349 | 0.159 to 0.798 | < 0.001 |
HCC: hepatocellular carcinoma; TACE: transcatheter arterial chemoembolization; ALP: alkaline phosphatase; ALB: albumin; AFP: alpha fetoprotein; BUN: blood urea nitrogen; TNM: tumour-node-metastasis; PVTT: portal vein tumour thrombus; AAPR: albumin-to-alkaline phosphatase ratio; NA: not applicable.
* Variables with a P value less than 0.05 were entered into multivariate analysis.